CD34+ Progenitor-Based Flow Cytometric Immunophenotypic Analysis Is Sensitive and Specific in Assessment of Myelodysplastic Syndromes.
G Tang, Y Zhou, JL Jorgensen, Y Hu, K Marian, LJ Medeiros, G Garcia-Manero, SA Wang - MD Anderson, Houston, TX
Secondary MDS: p53 and CD117 in the Bone Marrow Biopsy May Be Relevant Prognostic Markers.
RSS Tanizawa, EDRP Velloso, SAC Siqueira, R Rosenfeld, R Azevedo, VL Aldred, MCN Zerbini - University of Sao Paulo School of Medicine, SP, Brazil; UNIFESP School of Medicine, Sao Paulo, SP, Brazil
Therapy-Related Myelodysplastic Syndrome (MDS) Lacking High-Risk Karyotype Resembles De Novo Disease and Differs from Conventional Therapy-Related MDS.
RP Hasserjian, Y OK Chi, Y Hu, M Kluk, E Attar, SA Wang - Massachusetts General Hospital, Boston; UMass Medical Center, Worcester, MA; UT MD Anderson Cancer Center, Houston, TX; Brigham & Women's Hospital, Boston, MA
Ring Sideroblasts and a Normal Karyotype in Bone Marrow of Patients Treated for Primary Malignancies and Developed Cytopenia.
CY Ok, Y Zhou, Y Hu, LJ Medeiros, S Wang - University of Massachusetts, Worcester; UT MD Anderson Cancer Center, Houston, TX
The Pathologic Spectrum of Myelodysplastic Syndrome with Isolated del(5q): A Retrospective Study of 80 Cases.
D Chen, JD Hoyer, MM Patnaik, RP Ketterling, A Tefferi, CA Hanson - Mayo Clinic, Rochester, MN
Clinicopathologic Study of Isolated Del(20q) in De Novo Myelodysplastic Syndrome: A Group with Favorable Prognosis and No Evidence of Common Oncogenic Mutations.
R Kanagal Shamanna, RN Miranda, CC Yin, CE Bueso-Ramos, R Muddasani, LJ Medeiros, G Lu - UT MD Anderson Cancer Center, Houston, TX
Del(20q) in Patients with Chronic Lymphocytic Leukemia Is Associated with Prior Chemotherapy, Atypical Morphology, ZAP70 Expression, and Unmutated IGHV Genes.
CC Yin, G Lu, LJ Medeiros, X Feng, MJ Keating, LV Abruzzo - UT MD Anderson Cancer Center, Houston, TX
Translocation (6;9)- Related Myeloid Neoplasms in Children Are Diseases of Older Children with Variable Presentations.
J Joseph, A Sheehan, X Lu, T Elghetany - Baylor College of Medicine, Houston, TX; Texas Children's Hospital, Houston
Myelodysplastic/Myeloproliferative Neoplasm (MDS/MPN) with Isolated Isochromosome 17q [i(17q)]: An Aggressive Entity with Prominent Multilineage Dysplasia and Wild Type NPM1.
R Kanagal Shamannna, CC Yin, G Lu, M Nguyen, D Hoehn, G Garcia-Manero, S Vadhan-Raj, LJ Medeiros, C Bueso-Ramos - UT MD Anderson Cancer Center, Houston
Developing Epigenetic Profiling-Based Biomarkers for Flow Cytometry, Immunohistochemistry and Liquid-ChIP Assays in Myelodyplastic Syndrome.
JX Cheng, E Kleinbrink, J Hummel, S-S Kim - University of Michigan, Ann Arbor
EXEL-8232, a Small Molecule JAK2 inhibitor, Effectively Treats Thrombocytosis and Extramedullary Hematopoiesis in a Murine Model of Myeloproliferative Disease Induced by MPLW515L.
G Wernig, M Kharas, D Clary, G Gilliland, T George - Stanford Hospital & Clinics, Stanford University Medical School, CA; Brigham & Women's Hospital, Harvard Medical School, Boston, MA; Exelixis, San Francisco, CA
Distinct Histological Patterns of Splenic Extramedullary Hematopoiesis in Myeloproliferative Neoplasms Correlate with Clinical Behavior.
S Prakash, R Hoffman, S Barouk, DM Knowles, A Orazi - Weill Cornell Medical College, New York; Mount Sinai School of Medicine, New York
CD30 Expression in Mastocytosis.
AR Arredondo, CD Jennings, L Shier, U Sundram, J Gotlib, TI George - Stanford University School of Medicine, CA; University of Alberta Hospital, Edmonton, Canada
FISH Is Necessary To Distinguish MLLT10/MLL Fusion from MLLT10/CALM Fusion in Acute Leukemia with Chromosome 10p and 11q Rearrangements.
WR Sukov, RA Knudson, JG Keefe, RP Ketterling - Mayo Clinic, Rochester, MN
Utility of CD11a and CD18 in the Diagnosis of Acute Promyelocytic Leukemia by Flow Cytometric Immunophenotyping.
Y Zhou, JL Jorgensen, SA Wang, LJ Medeiros, SN Konoplev - University of Texas MD Anderson Cancer Center, Houston
Diagnostic Value of CD31 Immunohistochemistry in Evaluation of Acute Myeloid Leukemia with Megakaryocytic Differentiation.
M Su, D Rakheja, H-Y Wang, F Fuda, W Chen - UT Southwestern Medical Center, Dallas, TX
The Use of Pro-Apoptotic Marker, FoxO3 To Distinguish Erythroid Dominant Malignancies.
R Dewar, R Khosravi-Far - Beth Israel Deaconess Medical Center & Harvard Medical School, Boston, MA; Harvard Medical School, Boston, MA
Cytochemical and/or Immunohistochemical Staining for Myeloperoxidase Are Essential in the Work-Up of Mixed Phenotype Acute Leukemia.
J Emmons, JS Willis, NJ Karandikar, FS Fuda - University of Texas Southwestern Medical School, Dallas
Use of Classic and Novel Immunohistochemical Markers in the Diagnosis of Cutaneous Myeloid Sarcoma.
C Amador-Ortiz, MY Hurley, GK Ghahramani, S Frisch, KM Jeffery, AC Lind, T-D Nguyen, A Hassan, FH Kreisel, JL Frater - Washington University, St. Louis, MO; St. Louis University, MO